相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma
Gregory D. Jones et al.
JAMA SURGERY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons
David R. Jones et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers
Zsofia K. Stadler et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
Miklos Diossy et al.
NPJ PRECISION ONCOLOGY (2021)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma
Whitney S. Brandt et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization
Ekrem Emrah Er et al.
NATURE CELL BIOLOGY (2018)
Quantitative Analysis Reveals that Actin and Src-Family Kinases Regulate Nuclear YAP1 and Its Export
Nil Ege et al.
CELL SYSTEMS (2018)
Cytoplasmic Localization of RUNX3 via Histone Deacetylase-Mediated SRC Expression in Oxidative-Stressed Colon Cancer Cells
Kyoung Ah Kang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma
Erin M. Parry et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK
Elianna M. Amin et al.
SCIENCE SIGNALING (2017)
Comprehensive Analysis of the Human SH3 Domain Family Reveals a Wide Variety of Non-canonical Specificities
Joan Teyra et al.
STRUCTURE (2017)
p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
Evguenia M. Alexandrova et al.
CELL DEATH & DISEASE (2017)
Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners
Jakub Gemperle et al.
SCIENTIFIC REPORTS (2017)
The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK
Elianna M. Amin et al.
SCIENCE SIGNALING (2017)
A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain
Hiroto Makino et al.
SCIENTIFIC REPORTS (2017)
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
Michael R. Burgess et al.
CELL (2017)
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
D. Weekes et al.
ONCOGENE (2016)
CK2α′ Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation
Yuan Liu et al.
CANCER RESEARCH (2016)
Rs2853677 modulates Snail1 binding to the TERT enhancer and affects lung adenocarcinoma susceptibility
Xiaoting Li et al.
ONCOTARGET (2016)
Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity
Kwon Pyo Hong et al.
BIOMATERIALS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
MoDPepInt: an interactive web server for prediction of modular domain-peptide interactions
Kousik Kundu et al.
BIOINFORMATICS (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
SNPs in PI3K-PTEN-mTOR and Brain Metastases in NSCLC-Letter
Abolfazl Avan et al.
CLINICAL CANCER RESEARCH (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival
Michelle R. Roberts et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300
Yuan Liu et al.
CANCER RESEARCH (2013)
CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer
Jianmin Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Sipa1 Promoter Polymorphism Predicts Risk and Metastasis of Lung Cancer in Chinese
Chenli Xie et al.
MOLECULAR CARCINOGENESIS (2013)
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
Ana Slipicevic et al.
BMC CANCER (2012)
The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity
G. O. Ferrero et al.
ONCOGENE (2012)
SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non-Small-Cell Lung Cancer
Qianxia Li et al.
PLOS ONE (2012)
Occult Metastases in Lymph Nodes Predict Survival in Resectable Non-Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial
Valerie W. Rusch et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer
Philip W. Smith et al.
CANCER LETTERS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process
Pushkar A. Phadke et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen
Loaie Maraqa et al.
CLINICAL CANCER RESEARCH (2008)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis
Yuan Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role
Takanori Sasaki et al.
MOLECULAR CELL (2006)
Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer
ZB Hu et al.
CLINICAL CANCER RESEARCH (2005)
Shp2 regulates Src family kinase activity and Ras/Erk activation by controlling Csk recruitment
SQ Zhang et al.
MOLECULAR CELL (2004)
Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription
WJ Meehan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
AP-1: A double-edged sword in tumorigenesis
R Eferl et al.
NATURE REVIEWS CANCER (2003)
Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67phox, Grb2 and Pex13p
K Kami et al.
EMBO JOURNAL (2002)
The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients
SJ Elledge et al.
CANCER CELL (2002)
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
R Garcia et al.
ONCOGENE (2001)
分享论文
